Leukemia Clinical Trials

University of Alabama at Birmingham
Birmingham Alabama 35294

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

University of Alabama Comprehensive Cancer Center University of Alabama
Birmingham Alabama 35294

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

University of Alabama, Birmingham
Birmingham Alabama 35233

A Phase 2 clinical study for patients with Acute Myeloblastic Leukemia

Research Site
Birmingham Alabama

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia (CLL)

GSK Investigational Site
Birmingham Alabama 35294

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

Birmingham Alabama
Updated

Patients are needed to participate in a clinical research study of Ibrutinib, Bendamustine hydrochloride, Rituximab and Placebo to evaluate Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

University of Alabama Comprehensive Cancer Center
Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

University of Alabama at Birmingham
Birmingham Alabama 35294-3300
Updated

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

University of Alabama at Birmingham / Children's Hospital of Alabama
Birmingham Alabama 35233
Updated

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

University of Alabama at Birmingham
Birmingham Alabama 35294-3300

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Clearview Cancer Institute
Huntsville Alabama 35805

A clinical trial seeking patients for a research study for the treatment of B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Waldenstrom Macroglobulinemia

Clearview Cancer Institute
Huntsville Alabama 35805

A clinical trial seeking patients for a research study for the treatment of Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma

Clearview Cancer Institute
Huntsville Alabama 35805

A clinical trial seeking patients for a research study for the treatment of Leukemia Lymphocytic Chronic B-Cell

Clearview Cancer Center
Huntsville Alabama 35805

A clinical trial to evaluate treatments using CC-292 and Lenalidomide for patients with Leukemia Lymphocytic Chronic B-Cell

TG Therapeutics Investigational Trial Site
Huntsville Alabama 35805

A Phase 1/Phase 2 clinical study for patients using Ublituximab

Clearview Cancer Institute
Huntsville Alabama 35805

A Phase 3 clinical study for patients with Chronic Lymphocytic Leukemia

Clearview Cancer Institute
Huntsville Alabama 35805

Patients are needed to participate in a clinical research study evaluating Idelalisib + Rituximab and Placebo + Rituximab for the treatment of Chronic Lymphocytic Leukemia

TG Therapeutics Investigational Trial Site
Huntsville Alabama 35805

Patients are needed to participate in a clinical research study evaluating Ublituximab and Lenalidomide

Clearview Cancer Institute
Huntsville Alabama 35805

Patients are needed to participate in a clinical research study of Idelalisib to evaluate Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia or Multiple Myeloma

Northwest Alabama Cancer Center
Muscle Shoals Alabama 35661

A clinical research study for the treatment of Chronic Myeloid Leukemia

Northwest Alabama Cancer Center, PC
Muscle Shoals Alabama 35661

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Phoenix Arizona
Updated

Patients are needed to participate in a clinical research study of Ibrutinib, Bendamustine hydrochloride, Rituximab and Placebo to evaluate Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phoenix Children's Hospital
Phoenix Arizona

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Call for Information (Investigational Site 0004)
Scottsdale Arizona 85259

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia (AML)

Mayo Clinic
Scottsdale Arizona 85259

A clinical trial to evaluate treatments using GS-6624 at 700 mg and GS-6624 at 200 mg for patients with Myelofibrosis

Mayo Clinic
Scottsdale Arizona 85259

A Phase 1/Phase 2 clinical study for patients with MDS, CMML or AML

Mayo Clinic Arizona - Cancer Clinical Research Unit
Scottsdale Arizona 85259
Updated

Patients are needed to participate in a clinical research study evaluating CDX-1127

Mayo Clinic Scottsdale-Phoenix
Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study of EPZ-5676

Virginia G. Piper Cancer Center
Scottsdale Arizona 85258

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

Arizona Oncology Associates, PC - NAHOA
Sedona Arizona 86336

A clinical research study for the treatment of Chronic Myeloid Leukemia

Arizona Oncology Associates, PC - HOPE
Tucson Arizona 85704

A clinical research study for the treatment of Chronic Myeloid Leukemia

University of Arizona (SPORE)
Tucson Arizona 85719

A clinical trial seeking patients for a research study for the treatment of B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia or Waldenstrom Macroglobulinemia

Site Reference ID/Investigator# 52902
Tucson Arizona 85724-5024

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Site Reference ID/Investigator# 96748
Tucson Arizona 85724-5024

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

(210) University of Arizona Cancer Center
Tucson Arizona 85724

A Phase 2 clinical study for patients with Acute Myeloid Leukemia or Acute Myelogenous Leukemia

Arizona Oncology Associates
Tucson Arizona 85710
Updated

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Arizona Oncology Associates
Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Idelalisib + Rituximab and Placebo + Rituximab for the treatment of Chronic Lymphocytic Leukemia